Gapping down
In reaction to earnings/guidance:
- WW -23.7%, ONTF -20.9%, EPAY -11.1%, PRGO -9.5%, WIX -9.4%, NARI -7.6%, POSH -7.2%, GO -5.4%, BLI -4.1%, LUV -2.4%, PLBY -1.7%, ATC -1.3%, GOOS -1.1%
Other news:
- GTES -6.1% (stock offering)
- FGEN -2.3% (FDA has issued a complete response letter regarding the New Drug Application for roxadustat for the treatment of anemia of chronic kidney disease)
- HCAT -0.8% (prices offering of 4,245,283 shares of common stock at $53.00 per share)
- APAM -0.6% (reports July AUM)
- MRKR -0.5% (files for $300 mln mixed securities shelf offering)
Analyst comments:
- ARCT -5.9% (downgraded to Sell from Neutral at Goldman)
- BHLB -1.9% (downgraded to Neutral from Overweight at Piper Sandler)
- DRNA -1.7% (downgraded to Neutral from Buy at Goldman)
- CHMI -1.1% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)